.Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A10B_BloodGlucoseLoweringDrugsExclInsulins.A10BD10_MetforminAndSaxagliptin.MetforminAndSaxagliptin .Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A10B_BloodGlucoseLoweringDrugsExclInsulins.A10BD10_MetforminAndSaxagliptin.MetforminAndSaxagliptin| name: | MetforminAndSaxagliptin |
| ATC code: | A10BD10 | route: | oral |
| n-compartments | 1 |
Combination of metformin, a biguanide antihyperglycemic agent, and saxagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor. Used for the treatment of type 2 diabetes mellitus to improve glycemic control, as an adjunct to diet and exercise. Approved for use in multiple regions.
Estimated pharmacokinetic parameters for healthy adults based on published data for individual components; no direct published pharmacokinetics of combination found.